$IFF

Read Analyst Questions From International Flavors & Fragrances’s Q2 Earnings Call

International Flavors & Fragrances (IFF) reported Q2 results driven by volume growth in Scent, Taste, and Health & Biosciences, with productivity improvements and margin discipline. Q2 revenue fell to $1.95B vs $2.61B estimates, and adjusted EPS was $0.82 vs $1.12. Full-year revenue guidance was cut to $7.5B midpoint from $10.65B. CEO said Food Ingredients divestiture is likely the last major portfolio change.

Original reporting
Published Aug 11, 2026, 7:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 7:23 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Read Analyst Questions From International Flavors & Fragrances’s Q2 Earnings Call — source image
Decision brief

The 30-second read

$IFFBearishMed
01

Why it matters

The most tradable new information is the combination of Q2 misses and full-year guidance reductions, plus management’s quantified stranded-cost remediation timeline and margin recovery expectations.

02

Market read

Traders will likely reprice IFF’s earnings trajectory based on the guidance cut and stranded-cost/margin recovery path, while monitoring buyback execution and volume resilience.

03

What to watch

Working capital impacts from the Food Ingredients divestiture and the pace of R&D-driven product launches may be key to whether margins recover faster than the market expects.

Relevance 8/10Novelty 6/10Timing: pre-market today, ahead of trader positioning around guidance and stranded-cost remediation

Background

The article summarizes IFF’s Q2 performance and highlights analyst Q&A themes around the Food Ingredients divestiture, stranded costs, demand resilience, and input-cost inflation.

Company-level read

Ticker impact

$IFFBearishMedium confidence
Context

IFF reported Q2 results with revenue and adjusted EPS far below estimates, and cut full-year revenue and EBITDA guidance midpoints.

Expected impact

Bias toward continued volatility and downside risk until stranded-cost remediation and margin recovery become clearer.

Evidence & confidence

The article discloses large misses versus consensus and a substantial full-year revenue guidance reduction, which typically outweighs offsetting positives like organic revenue growth and free cash flow commentary.

Market effects

Signals pressure in specialty ingredients demand and cost pass-through, with investors focusing on margin execution and portfolio restructuring outcomes.

No specific regional catalyst beyond global consumer and input-cost sensitivity implied by the inflation and pricing questions.

Could affect read-across for other flavors and fragrances and specialty chemicals names sensitive to energy, logistics, and restructuring costs.

Counterpoint

Organic revenue growth and management’s stated stranded-cost elimination plan could mean the guidance cut is front-loaded conservatism rather than a durable demand deterioration.

Key entities

  • International Flavors & Fragrances

    Subject of the article, reporting Q2 results and cutting full-year revenue and EBITDA guidance amid stranded-cost margin pressure from the Food Ingredients divestiture.

  • Jon Erik Fyrwald

    CEO quoted on volume growth, margin execution, free cash flow, and stranded-cost remediation progress.

  • Michael Deveau

    CFO quoted on growth guidance rationale and input-cost inflation and pricing lag.

Related articles

$DARMedAI 8/10

A Look Back at Ingredients, Flavors & Fragrances Stocks’ Q2 Earnings: Darling Ingredients (NYSE:DAR) Vs The Rest Of The Pack

Ingredients, flavors, and fragrances stocks reported mixed Q2 earnings, with revenues missing estimates by 2.4%. Darling Ingredients (DAR) reported $1.72B revenue, up 16.4% YoY, beating estimates. Archer-Daniels-Midland (ADM) reported $22.68B revenue, up 7.2% YoY, outperforming estimates. International Flavors & Fragrances (IFF) reported $1.95B revenue, down 29.3% YoY, missing estimates. Ingredion (INGR) reported $1.85B revenue, flat YoY, topping estimates. Bunge Global (BG) reported $24.04B rev

$IFFMedAI 8/10

IFF (IFF) Q2 2026 Earnings Call Transcript

International Flavors & Fragrances (IFF) reported Q2 2026 revenue from continuing operations of $1.95 billion, up 6% currency-neutral, and adjusted EPS ex amortization of $0.82. Adjusted operating EBITDA was $408 million. The company plans a $4.3 billion Food Ingredients divestiture, $1B+ debt reduction, and a $2.5 billion share buyback. 2026 guidance: revenue $7.4B-$7.6B, EBITDA $1.53B-$1.60B.

$IFFMedAI 8/10

International Flavors & Fragrances Q2 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q2 segment results: Taste sales rose 4% to $688M, Health & Biosciences sales rose 5% to $601M, and Scent sales rose 8% to $665M. EBITDA increased across segments. IFF agreed to sell Food Ingredients to CVC for about $4.3B, and set 2026 guidance for $7.4B-$7.6B sales and $1.53B-$1.6B EBITDA.

$IFFMed

Why International Flavors & Fragrances (IFF) Is Up 6.4% After New $2.5 Billion Buyback And Guidance

International Flavors & Fragrances (IFF) reported Q2 2026 sales of US$1,954 million and net income of US$50 million, with full-year guidance updated for discontinued operations. The company also authorized a new US$2.5 billion share repurchase and reaffirmed its quarterly dividend. The article links the buyback and portfolio reshaping to IFF’s risk and cash-generation outlook.

$IFFMed

Why is International Flavors & Fragrances stock climbing today?

International Flavors & Fragrances (IFF) shares rose 0.8% in pre-open trading. The company said it will sell its Food Ingredients business to CVC Capital Partners for about $4.3 billion, expected to close by end of Q2 2027, and announced a $2.5 billion share repurchase. Q2 adjusted EPS was $0.82 vs $1.09 expected, revenue $1.95B vs $2.68B, but core results improved. Oppenheimer raised its IFF price target to $95 from $90.